Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 7;10(1):89.
doi: 10.1038/s41537-024-00505-w.

Multivariable prediction of functional outcome after first-episode psychosis: a crossover validation approach in EUFEST and PSYSCAN

Collaborators, Affiliations

Multivariable prediction of functional outcome after first-episode psychosis: a crossover validation approach in EUFEST and PSYSCAN

Margot I E Slot et al. Schizophrenia (Heidelb). .

Abstract

Several multivariate prognostic models have been published to predict outcomes in patients with first episode psychosis (FEP), but it remains unclear whether those predictions generalize to independent populations. Using a subset of demographic and clinical baseline predictors, we aimed to develop and externally validate different models predicting functional outcome after a FEP in the context of a schizophrenia-spectrum disorder (FES), based on a previously published cross-validation and machine learning pipeline. A crossover validation approach was adopted in two large, international cohorts (EUFEST, n = 338, and the PSYSCAN FES cohort, n = 226). Scores on the Global Assessment of Functioning scale (GAF) at 12 month follow-up were dichotomized to differentiate between poor (GAF current < 65) and good outcome (GAF current ≥ 65). Pooled non-linear support vector machine (SVM) classifiers trained on the separate cohorts identified patients with a poor outcome with cross-validated balanced accuracies (BAC) of 65-66%, but BAC dropped substantially when the models were applied to patients from a different FES cohort (BAC = 50-56%). A leave-site-out analysis on the merged sample yielded better performance (BAC = 72%), highlighting the effect of combining data from different study designs to overcome calibration issues and improve model transportability. In conclusion, our results indicate that validation of prediction models in an independent sample is essential in assessing the true value of the model. Future external validation studies, as well as attempts to harmonize data collection across studies, are recommended.

PubMed Disclaimer

Conflict of interest statement

N.K. received honoraria for talks presented at education meetings organized by Otsuka/Lundbeck. W.W.F. has received grants from Lundbeck and Otsuka and lecture honoraria from Sumitomo-Pharma and Forum Medizinische Fortbildung. S.G. received advisory board/consultant fees from the following drug companies: Angelini, Boehringer Ingelheim Italia, Gedeon Richter-Recordati, Janssen Pharmaceutica NV and ROVI. S.G. received honoraria/expenses from the following drug companies: Angelini, Gedeon Richter-Recordati, Janssen Australia and New Zealand, Janssen Pharmaceutica NV, Janssen-Cilag, Lundbeck A/S, Lundbeck Italia, Otsuka, Recordati Pharmaceuticals, ROVI, Sunovion Pharmaceuticals. B.Y.G. has been the leader of a Lundbeck Foundation Centre of Excellence for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS) (January 2009–December 2021), which was partially financed by an independent grant from the Lundbeck Foundation based on international review and partially financed by the Mental Health Services in the Capital Region of Denmark, the University of Copenhagen, and other foundations. All grants are the property of the Mental Health Services in the Capital Region of Denmark and administrated by them. The other authors declare no competing interests.

Figures

Fig. 1
Fig. 1. A comparison of the most important predictive baseline variables per classifier based on the sign-based consistency resulting from the inner cross-validation cycles.
Significant predictors overlapping across the models are presented only. Variables with a sign-based consistency * Pfdr log10 ≥ 1.36 are considered significant (dotted line reflects the significance threshold). EUFEST classifier = pooled non-linear cross-validated SVM model on EUFEST cohort. PSYSCAN classifier = pooled non-linear cross-validated SVM model on PSYSCAN cohort. Leave-site-out classifier = leave site-out inner pooled cross-validated SVM model on the merged dataset (sites that included < 10 participants were excluded).
Fig. 2
Fig. 2. Cross-validation ratios (CVR) of the significant predictive baseline variables overlapping across the models.
The green lines reflect the 95% confidence threshold (CVR = ± 2). a EUFEST classifier = internally cross-validated SVM model on EUFEST data. b PSYSCAN classifier = internally cross-validated SVM model on PSYSCAN data. c Leave-site-out classifier = inner pooled/outer leave-site-out cross-validated SVM model on the merged dataset (sites that included < 10 participants were excluded). Positive CV ratios indicate that the variable contributes to the classification of the poor outcome label, whereas negative CV ratios indicate the opposite. The absolute CV ratio values indicate how strongly the variable affects the decision towards the outcome label (i.e., a variable with a higher absolute CV ratio drives the decision more strongly towards the classification of the outcome label than a variable with a lower absolute CV ratio).

References

    1. Soldatos, R. F. et al. Prediction of early symptom remission in two independent samples of first-episode psychosis patients using machine learning. Schizophr. Bull.48, 122–133 (2022). - PMC - PubMed
    1. de Wit, S. et al. Individual prediction of long-term outcome in adolescents at ultra-high risk for psychosis: Applying machine learning techniques to brain imaging data. Hum. Brain Mapp38, 704–714 (2017). - PMC - PubMed
    1. Nieuwenhuis, M. et al. Multi-center MRI prediction models: predicting sex and illness course in first episode psychosis patients. Neuroimage145, 246–253 (2017). - PMC - PubMed
    1. Rosen, M. et al. Towards clinical application of prediction models for transition to psychosis: a systematic review and external validation study in the PRONIA sample. Neurosci. Biobehav. Rev.125, 478–492 (2021). - PubMed
    1. Leighton, S. P. et al. Predicting one-year outcome in first episode psychosis using machine learning. PLoS ONE14, e0212846 (2019). - PMC - PubMed

LinkOut - more resources